Kaposi's sarcoma in patients with and without human immunodeficiency virus infection, in a tertiary referral centre in Kenya

Annals of Tropical Medicine and Parasitology

Volumn 99, Issue 1, 2005, Pages 81-91

  Mwanda, O W ^a   Fu, P ^b,c   Collea, R ^b   Whalen, C ^b   Remick, S C ^b,c  

^a UNIVERSITY OF NAIROBI   (Kenya)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; DOXORUBICIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DEVELOPING COUNTRY; DISEASE ASSOCIATION; DISEASE COURSE; ENDEMIC DISEASE; EPIDEMIC; FEMALE; HEALTH CENTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; KAPOSI SARCOMA; KENYA; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT MONITORING; PREDICTION; PREVALENCE; PROSPECTIVE STUDY; SURVIVAL RATE; SYMPTOM;

ADULT; AGE DISTRIBUTION; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; KENYA; LYMPHATIC DISEASES; MALE; PROSPECTIVE STUDIES; SARCOMA, KAPOSI; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 12444344632     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1179/136485905X19928     Document Type: Article

References (41)

1. Anon. (1981). Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men - New York city and California. Morbidity and Mortality Weekly Report, 30, 305-308.
2. Anon. (1990). Kenya National Census 1989. Nairobi: Central Bureau of Statistics.
3. Anon. (1995). Annual Report -1995. Nairobi: Kenya National AIDS Programme.
4. Anon. (2000). Highly active antiretroviral therapy and the incidence of cancer in human immunodeficiency virus-infected adults. Journal of the National Cancer Institute, 92, 1823-1830.
5. Antman, K. & Chang, Y. (2000). Kaposi's sarcoma. New England Journal of Medicine, 342, 1027-1038.
6. Basset, M. T., Chokunonga, E., Mauchaza, B., Levy, L., Ferlay, J. & Parkin, D. M. (1995). Cancer in the African population of Harare, Zimbabwe, 1990-1992. International Journal of Cancer, 63, 29-36.
7. Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M. & Moore, P. S. (1994). Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science, 266, 1865-1869.
8. Cook-Mozaffari, P., Newton, R., Beral, V. & Burkitt, D. P. (1998). The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic. British Journal of Cancer, 78, 1521-1528.
9. Cox, D. R. (1972). Regression models and life-tables (with discussion). Journal of the Royal Statistical Society, Series B, 34, 187-220.
10. Dezube, B. J. (1996). Clinical presentation and natural history of AIDS-related Kaposi's sarcoma. Hematology/oncology Clinics of North America, 10, 1023-1029.
11. Dezube, B. J. (2000). Acquired immunodeficiency syndrome-related Kaposi's sarcoma: clinical features, staging, and treatment. Seminars in Oncology, 27, 424-430.
12. Fenig, E., Brenner, B., Rakowsky, E., Lapidoth, M., Katz, A. & Suike, A. (1998). Classic Kaposi's sarcoma. Experience at Rabin Medical Centre in Israel. American Journal of Clinical Oncology, 21, 498-500.
13. Gill, P. S., Tsai, Y. C., Rao, A. P., Spruck III, C. H., Zheng, T., Harrington Jr, W. A., Cheung, T., Nathwani, B. & Jones, P. A. (1998). Evidence for multiclonality in multicentric Kaposi's sarcoma. Proceedings of the National Academy of Sciences of the United States of America, 95, 8257-8261.
14. Goedert, J. J. (2000). The epidemiology of acquired immunodeficiency syndrome malignancies. Seminars in Oncology, 27, 390-401.
15. Hutt, M. S. (1983). Classical and endemic form of Kaposi's sarcoma. A review. Antibiotics and Chemotherapy, 32, 12-17.
16. Hymes, K. B., Greene, J. B., Marcus, A., William, D. C., Cheung, T., Prose, N., Ballard, H. & Laubenstein, L. J. (1981). Kaposi's sarcoma in homosexual men - a report of eight cases. Lancet, ii, 598-600.
17. Kaplan, E. L. & Meier, P. (1958). Non-parametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457-481.
18. Kaposi, M. (1872). Idiopathisches multiples pigment-sarkom der haut. Archiv fur Dermatologie und Syphilis (Berlin), 4, 265-273.
19. Krigel, R. L. & Friedman-Kien, A. E. (1990). Epidemic Kaposi's sarcoma. Seminars in Oncology, 17, 350-360.
20. Kungu, A. & Gatei, D. G. (1981). Kaposi's sarcoma in Kenya. A retrospective clinicopathological study. Antibiotics and Chemotherapy, 29, 38-55.
21. Laor, Y. & Schwartz, R. A. (1979). Epidemiologic aspects of American Kaposi's sarcoma. Journal of Surgical Oncology, 12, 299-303.
22. Lothe, F. (1963). Kaposi's sarcoma in Uganda Africans. Acta Pathologica et Microbiologica Scandinavica, 83 (Suppl. 161), 1-70.
23. Martin III, R. W., Hood, A. F. & Farmer, E. R. (1993). Kaposi sarcoma. Medicine, 72, 245-261.
24. Melnick, P. J. (1971). Generalized primary angiosarcomatosis of the lymph nodes. Archives of Pathology, 91, 760-769.
25. Moore, P. S. & Chang, Y. (1995). Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. New England Journal of Medicine, 332, 1181-1185.
26. Olweny, C. L. M. (1981). Management of Kaposi's sarcoma. Chemotherapy II. Antibiotics and Chemotherapy, 29, 88-95.
27. Orem, J., Otieno, M. W. & Remick, S. C. (2004). AIDS-associated cancer in developing nations. Current Opinion in Oncology, 16, 468-476.
28. Parkin, D. M., Wabinga, H., Nambooze, S. & Wabwire-Mangen, F. (1999). AIDS-related cancers in Africa: maturation of the epidemic in Uganda. AIDS, 13, 2563-2570.
29. Reynolds, W. A., Winelmann, R. K. & Soule, E. H. (1965). Kaposi's sarcoma: a clinicopathologic study with particular reference to it's relationship to the reticuloendothelial system. Medicine, 44, 419-423.
30. Safai, B., Johnson, K. G., Myskowski, P. L., Koziner, B., Yang, S. Y., Cunningham-Rundles, S., Godbold, J. H. & Dupont, B. (1985). The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome. Annals of Internal Medicine, 103, 744-750.
31. Sitas, F. & Newton, R. (2001). Kaposi's sarcoma in South Africa. Journal of the National Cancer Institute, Monographs, 28, 1-4.
32. Smith, K. J., Nelson, A., Angritt, P., Morz, A. & Skelton, H. G. (1999). Kaposi's sarcoma in women: a clinicopathologic study. Journal of Cutaneous Medicine and Surgery, 3, 132-139.
33. Templeton, A. C. (1981). Kaposi's sarcoma. Pathology Annual, 16, 315-336.
34. Templeton, A. C. & Bhana, D. (1975). Prognosis in Kaposi's sarcoma. Journal of the National Cancer Institute, 55, 1301-1304.
35. Tappero, J. W., Conant, M. A., Wolfe, S. F. & Berger, T. G. (1993). Kaposi's sarcoma. Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria, and therapy. Journal of the American Academy of Dermatology, 28, 371-395.
36. Taylor, J. F., Templeton, A. C., Vogel, C. L., Ziegler, J. L. & Kyalwazi, S. K. (1971). Kaposi's sarcoma in Uganda: a clinico-pathological study. International Journal of Cancer, 8, 122-135.
37. Vogel, C. H., Primack, A., Dhru, D., Briers, F., Owor, R. & Kyalwazi, S. K. (1973). Treatment of Kaposi's sarcoma with a combination of actinomycin D and vincristine: results of a randomized trial. Cancer, 31, 1382-1389.
38. Wabinga, H. R., Parkin, D. M., Wabwire-Mangen, F. & Mugerwa, J. W. (1993). Cancer in Kampala, Uganda in 1989-91: changes in incidence in the era of AIDS. International Journal of Cancer, 54, 26-36.
39. Wabinga, H. R., Parkin, D. M., Wabwire-Mangen, F. & Nambooze, S. (2000). Trends in cancer incidence in Kyadondo county, Uganda, 1960-1997. British Journal of Cancer, 82, 1585-1592.
40. Wang, C.-Y. E., Schroeter, A. L. & Su, W. P. D. (1995). Acquired immunodeficiency syndrome-related Kaposi's sarcoma. Mayo Clinics Proceedings, 70, 869-879.
41. Ziegler, J. L., Templeton, A. C. & Vogel, C. L. (1984). Kaposi's sarcoma: a comparison of classical, endemic, and epidemic forms. Seminars in Oncology, 11, 47-52.